This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 101/11/1096    most recent CIRCRESAHA.107.154351v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Weber, S. Articles by Feil, R. Search for Related Content PubMed PubMed Citation Articles by Weber, S. Articles by Feil, R. Related Collections Animal models of human disease Cell signalling/signal transduction Peripheral vascular disease Endothelium/vascular type/nitric oxide Related Article

(Circulation Research. 2007;101:1096.)
© 2007 American Heart Association, Inc.

Molecular Medicine

Rescue of cGMP Kinase I Knockout Mice by Smooth Muscle–Specific Expression of Either Isozyme

Silke Weber, Dominik Bernhard, Robert Lukowski, Pascal Weinmeister, René Wörner, Jörg W. Wegener, Nadejda Valtcheva, Susanne Feil, Jens Schlossmann, Franz Hofmann, Robert Feil

From the Institut für Pharmakologie und Toxikologie der Technischen Universität (S.W., D.B., R.L., P.W., R.W., J.W.W., J.S., F.H.), München; Interfakultäres Institut für Biochemie (N.V., S.F., R.F.), Universität Tübingen, Germany. J.S. is currently at the Institut für Pharmakologie und Toxikologie, Universität Regensburg, Germany.

Correspondence to Dr Franz Hofmann, Institut für Pharmakologie und Toxikologie der Technischen Universität, Biedersteiner Str. 29, D-80802 München, Germany. E-mail hofmann{at}ipt.med.tu-muenchen.de

Smooth muscle expresses the I and the Iß isoforms of cGMP-dependent protein kinase I (cGKI). Inactivation of the murine cGKI gene prkg1 leads to multiple phenotypes and premature death at 6 weeks. We reconstituted mice with the cGKI or -Iß isozyme to test which isozyme was needed to support basic smooth muscle functions. Mice were generated by gene targeting. The cGKI or the -Iß coding sequences were placed under the control of the SM22 promoter to express either isoform selectively in smooth muscle cells (SM-I or SM-Iß transgene). To generate smooth muscle–specific cGKI or cGKIß rescue mice, the SM-I or SM-Iß transgenes were crossed on a cGKI^–/– genetic background. The levels of cGKI or -Iß expression were comparable to endogenous cGKI expression in wild-type aortic and intestinal smooth muscles. In cGKI or -Iß rescue mice, expression of the isozymes was not detectable in non–smooth muscle tissues and cells. Median survival time of the I and Iß rescue mice was 52 weeks. Both isozymes mediated the 8-bromo-cGMP–induced relaxation of precontracted jejunum and aorta muscle strips. Activation of both isozymes reduced hormone- or K⁺-induced [Ca²⁺]_i levels. The cGKI and cGKIß rescue mice did not show a significant difference in intestinal passage time of BaSO₄ in comparison with wild-type animals. Telemetric blood pressure measurements in conscious freely moving animals did not show differences between rescues and control mice in basal blood pressure and its regulation by DETA-NO, sodium nitroprusside, carbachol, or Y-27632. These results show that cGKI in smooth muscle is essential and that either cGKI isozyme alone can rescue basic vascular and intestinal smooth muscle functions.

Key Words: cGMP kinase isozymes • PKG • nitric oxide • smooth muscle • blood pressure

Related Article:

cGMP-Dependent Protein Kinase I and Smooth Muscle Relaxation: A Tale of Two Isoforms

Howard K. Surks
Circ. Res. 2007 101: 1078-1080. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				C. R. Rosenfeld, X.-t. Liu, and K. DeSpain Pregnancy modifies the large conductance Ca2+-activated K+ channel and cGMP-dependent signaling pathway in uterine vascular smooth muscle Am J Physiol Heart Circ Physiol, June 1, 2009; 296(6): H1878 - H1887. [Abstract] [Full Text] [PDF]

				H. Suzuki, K. Kimura, H. Shirai, K. Eguchi, S. Higuchi, A. Hinoki, K. Ishimaru, E. Brailoiu, D. N. Dhanasekaran, L. N. Stemmle, et al. Endothelial Nitric Oxide Synthase Inhibits G12/13 and Rho-Kinase Activated by the Angiotensin II Type-1 Receptor: Implication in Vascular Migration Arterioscler. Thromb. Vasc. Biol., February 1, 2009; 29(2): 217 - 224. [Abstract] [Full Text] [PDF]

				N. Valtcheva, P. Nestorov, A. Beck, M. Russwurm, M. Hillenbrand, P. Weinmeister, and R. Feil The Commonly Used cGMP-dependent Protein Kinase Type I (cGKI) Inhibitor Rp-8-Br-PET-cGMPS Can Activate cGKI in Vitro and in Intact Cells J. Biol. Chem., January 2, 2009; 284(1): 556 - 562. [Abstract] [Full Text] [PDF]

				C. Paul, F. Schoberl, P. Weinmeister, V. Micale, C. T. Wotjak, F. Hofmann, and T. Kleppisch Signaling through cGMP-Dependent Protein Kinase I in the Amygdala Is Critical for Auditory-Cued Fear Memory and Long-Term Potentiation J. Neurosci., December 24, 2008; 28(52): 14202 - 14212. [Abstract] [Full Text] [PDF]

				M. Foller, S. Feil, K. Ghoreschi, S. Koka, A. Gerling, M. Thunemann, F. Hofmann, B. Schuler, J. Vogel, B. Pichler, et al. Anemia and splenomegaly in cGKI-deficient mice PNAS, May 6, 2008; 105(18): 6771 - 6776. [Abstract] [Full Text] [PDF]

				B. Kemp-Harper and R. Feil Meeting Report: cGMP Matters Sci. Signal., March 4, 2008; 1(9): pe12 - pe12. [Abstract] [Full Text] [PDF]

				H. K. Surks cGMP-Dependent Protein Kinase I and Smooth Muscle Relaxation: A Tale of Two Isoforms Circ. Res., November 26, 2007; 101(11): 1078 - 1080. [Full Text] [PDF]